摘要
中医作为一种很典型的经验医学,其疗效缺乏客观化、定量化的评价标准,是中医药走向世界、获得广泛认可的最大障碍之一。循证医学概念的引入,为中医药研究带来了良好的机遇和切入点,我们在国家十五攻关期间进行了中医药干预冠心病介入治疗后再狭窄的临床研究,在实践中体会到循证医学确实是指导中医药临床研究的重要原则,但应合理应用随机对照研究方法,注意规范化研究设计如样本量估计、随机隐藏、盲法的延伸和对照的选择,并加强实施过程的质量控制,以期为中医药干预措施的疗效评价提供客观证据。
As traditional Chinese medicine （TCM） attach importance to clinic, shortage of objective and quantitative criteria in evaluating therapeutic effect is one of the largest obstacles for TCM to move toward the world and win wide approval. The introduction of evidence-based medicine （EBM） concept brings favorable opportunity to research on TCM. The authors have conducted clinical studies on restenosis after percutaneous coronary intervention （PCI） intervened by TCM, in the period of Tenth Five-Year Project, and realized EBM was indeed a vital principle for clinical study on TCM. However, randomized controlled trial should be applied reasonably, attention should be paid to the standardized design of research, including estimation of sample size, concealment of randomized sequence, extension of blindness and selection of control, and stress should be put on the quality control in implementation, so as to provide objective evidence for effect evaluation of TCM treatment.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
2006年第6期489-492,共4页
Chinese Journal of Integrated Traditional and Western Medicine
关键词
循证医学
介入治疗
再狭窄
evidence-based medicine
intervention treatment
restenosis
